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Abstract
Background: Meningitis is notoriously difficult to diagnose in infancy because its clinical features are non-specific.
World Health Organization (WHO) guidelines suggest several indicative signs, based on limited data. We aimed to
identify indicators of bacterial meningitis in young infants in Kenya, and compared their performance to the WHO
guidelines. We also examined the feasibility of developing a scoring system for meningitis.
Methods: We studied all admissions aged < 60 days to Kilifi District Hospital, 2001 through 2005. We evaluated
clinical indicators against microbiological findings using likelihood ratios. We prospectively validated our findings
2006 through 2007.
Results: We studied 2,411 and 1,512 young infants during the derivation and validation periods respectively.
During derivation, 31/1,031 (3.0%) neonates aged < 7 days and 67/1,380 (4.8%) young infants aged 7-59 days (p <
0.001) had meningitis. 90% of cases could be diagnosed macroscopically (turbidity) or by microscopic leukocyte
counting. Independent indicators of meningitis were: fever, convulsions, irritability, bulging fontanel and
temperature ≥ 39°C. Areas under the receiver operating characteristic curve in the validation period were 0.62 [95%
CI: 0.49-0.75] age < 7 days and 0.76 [95%CI: 0.68-0.85] thereafter (P = 0.07), and using the WHO signs, 0.50 [95%CI
0.35-0.65] age < 7 days and 0.82 [95%CI: 0.75-0.89] thereafter (P = 0.0001). The number needed to LP to identify
one case was 21 [95%CI: 15-35] for our signs, and 28 [95%CI: 18-61] for WHO signs. With a scoring system, a cut-off
of ≥ 1 sign offered the best compromise on sensitivity and specificity.
Conclusion: Simple clinical signs at admission identify two thirds of meningitis cases in neonates and young
infants. Lumbar puncture is essential to diagnosis and avoidance of unnecessary treatment, and is worthwhile
without CSF biochemistry or bacterial culture. The signs of Meningitis suggested by the WHO perform poorly in
the first week of life. A scoring system for meningitis in this age group is not helpful.
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Background
Meningitis, pneumonia and sepsis in neonates and
young infants (age < 60 days) are leading causes of
childhood death in developing countries [1,2]. These
conditions have usually been studied collectively as ‘ser-
ious bacterial infections’. Penicillin and gentamicin, are
recommended by the World Health Organization
( W H O )w h e r ea n yo ft h e s et h r e ec o n d i t i o n sa r es u s -
pected [3]. Meningitis is notoriously difficult to
distinguish clinically in this age group because its fea-
tures may be non-specific. In Bangladesh, [4] more than
a quarter of neonates with suspected sepsis; but without
clinical signs of meningitis, had CSF findings suggestive
of meningitis. The recognition of meningitis is impor-
tant given the high mortality and neuro-developmental
sequelae of the disease. The latter, may be higher in
case of a missed diagnosis or partial/inadequate duration
of treatment when an infant is managed for the less spe-
cific condition ‘neonatal sepsis’ [5-7].
The WHO guidelines list ‘specific’ (convulsions, bul-
ging fontanel) and ‘general’ (lethargy, coma, reduced
feeding, irritability, abnormal cry, apnoeic episodes)
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sent [3]. These guidelines are based on evidence from
the WHO multicentre study of the aetiology of serious
bacterial infections in young infants in low-income set-
tings, and expert opinion [8-10]. Independent predictors
of serious bacterial infection identified in the multicen-
tre study included feeding difficulty, lack of spontaneous
movement, fever, agitation, lower chest wall indrawing,
tachypnoea, grunting, cyanosis, convulsions, bulging fon-
tanel and slow capillary refill [10]. A reduced set of
signs performed as well as those from the WHO study
in predicting severe disease in young infants [11]. How-
ever, in all these analyses, meningitis was grouped with
bacteraemia, radiological diagnosed pneumonia, hypoxe-
mia and death as ‘severe disease’. Furthermore, the
WHO multicentre study included only 33 cases of con-
firmed meningitis in infants < 60 days old, with only six
in the first week of life. Hence, current guidelines for LP
or presumptive treatment for meningitis among neo-
nates and young infants in developing countries are
based on limited data. Furthermore, LP is an under-
used investigation among chi l d r e ni nK e n y a nh o s p i t a l s
[12]. This is partly because of the uncertainty of inter-
pretation without full biochemical and microbiological
analysis of CSF, which is lacking in most hospitals in
the region.
We have previously identified clinical indicators of
bacterial meningitis in children aged 60 days or more at
our hospital in rural Kenya [13] and the findings have
been incorporated into Kenyan national policy [13,14].
Here we report findings using similar methods among
2,411 young infants age < 60 days during a four-year
period validated using 1,512 young infant admissions
over the subsequent two years, and examine the ‘speci-
fic’ and ‘general’ signs suggested by WHO [3]. We also
determined the proportion of cases of meningitis that
could be diagnosed without CSF biochemistry or bacter-
ial culture and calculated the number of LPs needed to
be performed to identify one case of meningitis using
our indicators and those suggested by WHO. Finally we
examined the feasibility of developing a scoring system
using the identified clinical indicators to determine need
for LP and or presumptive treatment for acute bacterial
meningitis.
Methods
Location and patients
We conducted the study at Kilifi District Hospital,
Kenya. We prospectively collected data on all admis-
sions to identify clinical indicators of meningitis from
June 1
st 2001 to July 31
st 2005, and subsequently to vali-
date the findings from January 1
st 2006 to December
31
st 2007. The hospital is located in a rural area on the
Kenyan coast serving a population of ~240,000 who are
mainly rural farmers. Malaria is endemic and children
receive up to 120 infective mosquito bites per year. The
government of Kenya introduced Infant vaccination
against Haemophilus influenzae type b in December
2001. HIV infection is present in 6-8% of women
attending the hospital antenatal clinic. There is little
antibiotic pre-treatment before admission to hospital.
Procedures
We collected a standardized set of clinical and labora-
tory data (including a complete blood count and blood
culture) from all young infants at admission [15]. Clini-
cal officers and junior doctors trained in the recognition
of standardized clinical signs recorded their findings
directly on a computer database at admission before any
results from blood tests or LP were available. Clinical
management protocols followed national and WHO
recommendations [3,14]. Consent for use of the data
was obtained from the guardian of every child at the
point of admission. The Kenyan National Ethical Review
Committee approved the study.
The indications for LP were any suspicion of meningi-
tis or sepsis; impaired consciousness, inability to breast-
feed or convulsions. We delayed LP if cardiac or
respiratory compromise was present. Following admis-
sion, the clinical team reviewed all admissions at least
once daily and performed an LP if they subsequently
suspected meningitis. Neonates and young infants with
suspected invasive bacterial infection were treated with
benzyl penicillin (50,000 units/kg every 6-12 hours,
depending on age), plus gentamicin (3-7.5 mg/kg once
daily depending on age and weight) as recommended by
WHO [3]. Antimicrobial therapy, including increased
dosing with penicillin for meningitis, was guided by
laboratory findings and clinical response.
Cerebrospinal fluid (CSF) leukocyte count was deter-
mined with a modified Neubauer counting chamber. A
Gram stain and latex agglutination antigen testing for
Haemophilus influenzae type b and Streptococcus pneu-
moniae (Murex Diagnostics, UK) were performed if the
CSF leukocyte count was > 10 cells/μl[ 1 6 ] .C S Fw a s
cultured using standard techniques: 20 μlo fC S Fw a s
inoculated onto plates of 7% horse-blood agar and 5%
chocolate agar and incubated at 36·5°C for 18-24 h. We
further incubated plates without visible signs of growth
for additional 24 h. We discarded plates without growth
at this stage. We processed blood cultures using a BAC-
TEC
® 9050 system instrument (Becton Dickinson, New
Jersey, USA). Pathogens in CSF or blood culture were
identified by standard techniques [15,17].
For this analysis, we defined meningitis as a positive
CSF culture, or a positive CSF latex agglutination test,
or bacteria seen on Gram stain, or a CSF total leukocyte
count ≥ 50 cells/μl. Since the cut-off of ≥ 50 cells/μl
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we first confirmed its validity among neonates and
young infants by constructing a receiver operating char-
acteristic curve (ROC) for total CSF leukocyte count
versus CSF culture positivity (Figure 1). The area under
the curve was 0.90 [95%CI 0.83-0.97]. The point of max-
imum discrimination was at 54 leukocytes/μl. The posi-
tive predictive value (PPV) of ≥ 50 cells/μl for a positive
culture was 15% [95%CI 9.4-20.0], negative predictive
value (NPV) 99.7% [95%CI 99.5-99.9]. Where CSF cul-
ture was negative but the CSF leukocyte count was ≥ 50
cells/μl and the blood culture was positive, we regarded
the bacterial species isolated from blood culture as the
organism causing meningitis.
Statistical analysis
We excluded from the analysis infants who died before
an LP was performed, because we could not be certain
of their meningitis status. We classified those in whom
we did not perform an LP, but were discharged home
well as not having meningitis. We analysed data from
neonates in the first week of life separately because we
hypothesized that both the aetiology and the clinical
signs may differ. We investigated the diagnostic values
of individual clinical features by examining their positive
and negative likelihood ratios (LR) for meningitis. Vari-
ables found to have crude LRs of ≥ 1.5 or ≤0.67 were
regarded as potentially useful and were adjusted for the
potential confounding effects of related variables in a
multivariate analysis according to the method of Spie-
gelhalter and Knill-Jones [13,18,19]. We regarded as
independent clinical indicators and retained variables
with adjusted likelihood ratios (aLR) of ≥ 1.5 or ≤0.67
We derived practical screening rules from the indica-
tors identified in descending strength of their adjusted
positive LR. We then evaluated these rules by calculat-
ing the area under the ROC curves for the derivation
and validation data sets. In order to examine the feasi-
bility of developing a scoring system for meningitis, we
constructed simplified scores by assigning points
approximating to the natural logarithm of the adjusted
likelihood ratio for each indicator. Where potential for a
negative score existed, we added a constant. We also
evaluated these scores by calculating the area under the
ROC curves for the derivation and validation data sets.
In addition, ROC curves were used to determine the cut
off value with the best sensitivity and specificity in dis-
criminating between those with or without meningitis.
The negative predictive value (NPV) and the positive
predictive value (PPV) were also calculated.
Before undertaking the analysis, we used the method
of Hanley and McNeil to determine that the validation
dataset was sufficiently large to reject a null hypothesis
of no prediction (ROC area = 0.5), for areas of ≥
0.6 [20]. ROC areas were compared using the STATA
command roccomp for independent datasets, which
returns a chi-squared statistic [21]. For other compari-
sons, we compared proportions using the chi-squared
test with Fishers exact test where appropriate. We finally
calculated the number of LPs we needed to perform to
identify one case of meningitis using our signs and
those suggested by WHO. We did this by subtracting
the risk of meningitis in the group with indicator(s) of
interest from that of the group without indicators of
interest in order to obtain the absolute risk difference/
reduction. The inverse of this value is the number of
LPs we needed to perform to indentify a single case of
meningitis [22]. We performed all analysis using
STATA 9.2 (Stata Corp. USA).
Results
Of 2,877 young infants admitted in the derivation per-
iod, 1,415 (49%) were age < 7 days and 1,462 (51%)
were aged 7-59 days. 2,360 (82%) were delivered at
home. Among those admitted in the first week of life,
half were of low weight: 269 (19%) weighed < 1.5 Kg
and 427 (31%) were between 1.5 and 2.5 Kg. Among
infants who died, an LP was not performed in 381/447
(85%) infants admitted in the first week of life and 85/
128 (66%) infants aged 7 to 59 days. Most deaths
occurred within 48 hours and 40% of all deaths were
among neonates admitted on the first day of life.
Amongst those weighing < 1.5 Kg, overall case fatality
was 63%, mainly due to prematurity and birth asphyxia.
Thus, 466 neonates and young infants died before an LP
Figure 1 Receiver operating characteristic curve of CSF total
leukocyte count as a predictor of microbiologically confirmed
meningitis in Kenyan neonates and young infants.A=1 0
leukocytes per μl, B = 50 leukocytes per μl, C = 100 leukocytes per
μl, D = 500 leukocytes per μl.
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leaving 2,411 neonates and young infants: 1,031 (43%) in
the first week of life and 1,380 (57%) aged 7 to 59 days.
The flow chart of patients included in the study and the
number having an LP is as shown (Figure 2).
Meningitis was diagnosed less frequently in the first
week of life than at 7-59 days: 31 (3.0%) vs 67 (4.8%) (p
< 0.001). The commonest bacterial species were Strepto-
coccus pneumoniae, Group B Streptococcus and Haemo-
philus influenzae (table 1). Overall, 27/98 (28%)
meningitis cases could have been diagnosed by visual
inspection of a turbid CSF and a further 61 (62%) by
microscopic CSF leukocyte counting. A positive blood
culture was found in 70/98 (71%) cases of meningitis.
The case fatality ratios for young infants with meningitis
were 8/31 (26%) in the first week of life and 12/67
(18%) after the first week (P = 0.37).
Amongst infants in the first week of life, 316/1,031
(31%) had a history of fever including 24/31 (77%) of
those with meningitis (table 2). The crude LRs for his-
tory of fever or convulsions (partial or generalised) sug-
gested that these might be useful indicators. The
absence of a history of fever was strongly associated
with the absence of meningitis. Of examination findings,
agitation, bulging fontanel, and axillary temperature
were the only variables to have crude LRs suggestive of
predictive value (table 3). 12/31 (38.7%) cases on
meningitis had the specific signs of convulsion or bul-
ging fontanel. Place of delivery (home or hospital) was
not significantly associated with meningitis.
When adjusted in a multivariate model, a history of
fever, history of convulsions, irritability, bulging fontanel
and an axillary temperature ≥ 39°C remained indepen-
dent predictors of meningitis. Importantly, in the multi-
variate analysis, lack of a history of fever was strongly
associated with the absence of meningitis. A simplified
scoring system was constructed from these signs The
minimum possible score was 0 with a maximum of 6
(table 4). 26/361 (7.2%) infants in the first week of life
presenting with one or more of fever, convulsions, irrit-
ability, a bulging fontanel or an axillary temperature ≥
39°C had meningitis compared to 5/670 (< 1%) without
any of these signs (p < 0.001): sensitivity 84%, specificity
67%, PPV 7.2% and NPV 99.3%. Among infants in the
first week of life with one or more of the signs of
meningitis in young infants suggested by the current
WHO guidelines, 24/509 (4.7%) had meningitis com-
pared to 14/522 (2.7%) without any of these signs (P =
0.07).
Amongst young infants outside the first week of life,
62/67 (93%) with meningitis had a history of fever.
The absence of fever strongly predicted the absence of
meningitis (table 3). Variables with a crude positive
likelihood ratio ≥ 1.5 were convulsions, inability to
Figure 2 Flow chart of study participants.
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absence of spontaneous movements, abnormal or
absent cry and high axillary temperature. On multivari-
ate analysis, history of fever, convulsions, bulging fon-
tanel, agitation/irritability, and axillary temperature
remained independent indicators of meningitis. Like-
wise these variables had a similar score (table 4). 63/
986 (6.4%) infants age 7 to 59 days presenting with
one or more of fever, convulsions, irritability, a bulging
fontanel or an axillary temperature ≥ 39°C had menin-
gitis compared to 4/394(1%) without any of these signs
(p < 0.001): sensitivity 94%, specificity 30%, PPV 6.3%
and NPV 99.0% for meningitis. Among infants, age 7
to 59 days with one or more of the WHO suggested
signs of meningitis, 29/232 (12.5%) had meningitis
compared to 38/1,140 (3.3%) without any of these
signs (p < 0.001): sensitivity of 43%, a specificity of
84.4%, PPV 12.5% and NPV 96.6%.
Among both age groups, the scoring system using our
signs, the best compromise on sensitivity and specificity
was achieved with just a cut-off ≥ 1; ROC 0.79 (95%CI
0.75-0.84) sensitivity 90.8%, specificity 45.6% and did
not differ between the first week of life or thereafter (p
= 0.8). The WHO recommended signs had an ROC of
0.68 (95%CI 0.63-0.73) with a sensitivity 70.4%, specifi-
city 61.9%.
Validation
1,678 consecutively admitted neonates and young
infants, of whom 900 (54%) were admitted in the first
week of life and 778 (46%) aged 7-59 days were
admitted during the validation period. Of these, 166
(10%) (141 during the first week of life and 25 there-
after) died without an LP and thus only 1,512 were
included for validation. Overall 1,109 (66%) were born
at home. During this period LPs were performed in
Table 1 Bacterial species found in Kenyan neonates and young infants with meningitis
Derivation period Validation period
Firstweek of life Age 7 to 59 days First week of life Age 7 to59 days Total
Gram positive
Streptococcus pneumoniae 1 10 0 5 16
Group B Streptococci ** 2 5 0 6 13
Group A Streptococci 0 2 0 3 5
Group D Streptococci 1 0 1 0 2
Streptococcus viridans 00 11 2
Staphylococcus aureus 10 01 2
Gram positive cocci* 1 1 0 1 3
Gram positive rods 0 0 2 2 4
Clostridium difficile 00 01 1
Gram negative
Haemophilus influenzae 1 6 0 1 8
Enterobacter sp. 3 2 0 0 5
Non-typhoidal Salmonella sp. 0 3 0 4 7
Escherichia coli ** 02 10 3
Pseudomonas aeruginosa ** 11 00 2
Psedomonas cepacea 00 01 0
Klebsiella pneumoniae 11 01 3
Acinetobacter sp. 1 1 0 0 2
Aeromonas sp. 1 0 0 0 1
Kluyvera sp. 1 0 0 0 1
Vibrio cholera 10 00 1
Neisseria meningitidis 0 1 0 0 1
Shigella sp. 0 1 0 0 1
Gram negative rods* 1 1 0 0 2
No organism isolated*** 15 31 10 21 77
Total 32 68 15 48 163
* seen on Gram stain, but blood and CSF cultures and antigen tests were negative.
** One child grew E. coli and Group B Streptococci and another grew Pseudomonas aeruginosa and Acinetobacter sp.
in CSF the total is therefore 54 isolates from 98 cases of meningitis in the derivative period.
*** diagnosis based on CSF leukocyte count (see text).
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(71%) of those aged 7 to 59 days. The overall proportion
having an LP was greater in the validation period than
in the derivation period (p < 0.001).
Meningitis was present in 63 (4.2%), 15/759 (2.0%) in
the first week of life and 48/753 (6.4%) from 7-59 days.
This prevalence of meningitis did not differ to from the
derivation period either in the first week of life or 7-59
days (P = 0.45 & 0.13).
T h eo v e r a l la r e au n d e rt h eR O Cc u r v ef o rp r e d i c t i n g
meningitis with the indicators we had identified was 0.75
(95%CI 0.68-0.82). The area was (0.62(95%CI 0.49-0.75))
in the first week of life and (0.76(95%CI 0.68-0.85)) after
the first week of life. This difference did not reach statis-
tical significance (c
2 = 3.24, P = 0.07). The overall area
under the ROC curve for the signs suggested by WHO
was 0.74(95%CI 0.67-0.81). It was significantly different
(0.50(95%CI 0.35-0.65)) in the first week of life compared
to (0.82(95%CI 0.75-0.89)) after the first week of life, (c
2
= 14.69, P = 0.0001). The overall sensitivity using the
s i g n sw ed e r i v e d( 7 8 % ) ,w a sn ot significantly different
from the (70%) for the WHO signs. Likewise when
applied the devised simplified scoring system to the vali-
dation data set, the best compromise on sensitivity and
specificity was similarly achieved with just a cut-off ≥ 1;
sensitivity 77.8%, specificity 55.2%.
Overall, one case of meningitis would be identified for
every 21 (95% CI 15-35) infants who received an LP or
presumptive treatment on the basis of the signs we
found compared to 28 (95% CI 19-61) using the WHO
recommended signs (Table 5).
Discussion
Lumbar puncture with CSF microscopy, biochemical, and
microbiological analysis is the only means of accurately
diagnosing meningitis in young infants. We aimed to inde-
pendently identify simple indicators of meningitis that
could be used as a practical screening tool to detect infants
that warrant a LP and to evaluate the signs suggested by
WHO [3,12,13,16]. We also determined the feasibility of
developing a simplified scoring system for diagnosing
meningitis in neonates and young infants. We found that
‘specific’ signs of convulsion(s) and bulging fontanel were
relatively specific, but insensitive. We found no evidence
that the WHO ‘general’ signs of drowsiness, lethargy,
unconsciousness, or reduced feeding were predictive of
meningitis. Amongst clinical features not included in the
WHO guidelines, we found a history of fever or a mea-
sured temperature ≥ 39°C to be useful indicators of
meningitis. Importantly our finding that a cut-off of just ≥
1 on a simplified scoring system offered the best compro-
mise on sensitivity and specificity suggested that a scoring
system may not be desirable, rather that any neonates or
young infant with any one of the indicators indentified
should be fully investigated for meningitis.
The sensitivity of our signs and the WHO signs was
similar to that we previously found among older chil-
dren [13], suggesting that meningitis may not be more
Table 2 Crude likelihood ratios for meningitis for items of clinical history amongst neonates and young infants in the
derivative period.
First week of life Age 7 to 59 days
Sample
size
Without
meningitis
With
meningitis
Crude
LR
Samplesize Without
meningitis
With
meningitis
Crude
LR
Fever 1,031 No 708 7 0.30 1,341 438 5 0.22
Yes 292 24 2.65 866 62 1.40
Vomiting 787 No 714 24 1.00 1,380 1,212 63 1.02
Yes 48 1 0.78 101 4 0.78
Anyconvulsions 1,031 No 937 24 0.81 1,380 1,213 42 0.68
Yes 63 7 3.58 100 25 4. 90
Partial
convulsions
1,018 No 984 15 0.92 1,380 1,286 59 0.90
yes 16 3 6.05 27 8 5.81
Able to breast
feed
1,031 No 407 24 1.31 1,372 55 9 1.92
Yes 593 7 0.56 1,250 58 2.83
Born in hospital 1,031 No 632 25 1.28 1,373 1055 63 1.14
yes 368 6 0.53 250 5 0.39
Mwaniki et al. BMC Infectious Diseases 2011, 11:301
http://www.biomedcentral.com/1471-2334/11/301
Page 6 of 10difficult to identify in young infants. Importantly, our
finding that 15 to 35 newborns and young infants need
to be evaluated by LP to diagnose one case of meningitis
highlights the burden the disease in our setting com-
pared to a developed country where 30 to 90 newborns
may need to be evaluated to diagnose one case [23].
Overall both our signs and those suggested by WHO
had low specificity. However, given the seriousness of
meningitis, and challenges in diagnosis and management
especially in resource poor regions, clinical indicators
with good sensitivity, which may encourage a low
threshold for performing LP while retaining reasonable
specificity are desirable.
The clinical indicators that we found did not differ from
those found in infants aged 7-59 days, nor was there evi-
dence that these clinical indicators performed differently
in the first week of life. Our data suggest that LP or
empirical treatment for meningitis should be done among
infants in the first week of life who are sufficiently ill to
require hospital admission and are found to have any one
of the following clinical signs or complaints of a bulging
fontanel, an history of convulsion(s), measured axillary
temperature ≥ 39°C, agitation or irritable or report a his-
tory of fever. Infants with respiratory or circulatory com-
promise should receive parenteral antibiotics and an LP
should be performed later to determine the duration of
Table 3 Crude likelihood ratios for meningitis of items of clinical examination amongst neonates and young infants in
the derivation period.
First week of life Age 7 to 59 days
Sample
size
Without
meningitis
With
meningitis
Crude
LR
Sample
size
Without
meningitis
With
meningitis
Crude
LR
Neck stiffness 1,031 No 995 31 1.01 1,380 1,285 60 0.92
Yes 5 0 - 28 7 4.90
Bulging fontanel 1,031 No 990 26 0.85 1,380 1,300 56 0.84
Yes 10 5 16.13 13 11 16.58
Abnormal cry or none 1031 No 949 30 1.02 1,380 1,287 65 0.99
Yes 51 1 0.63 26 2 1.51
Irritability 1031 No 988 29 0.95 1,380 1,267 57 0.88
Yes 12 2 5.38 46 10 4.26
Spontaneous movements 1,031 No 27 0 - 1,390 13 3 4.52
Yes 973 31 1.07 1,300 64 0.97
Drowsy, lethargic or
unconscious
1,031 No 782 21 0.87 1,380 1,153 51 0.87
Yes 218 10 1.48 160 16 1.96
Capillary refill seconds 1,031 < 3 866 30 1.12 1,380 1,234 63 1.00
≥ 3 134 1 0.24 79 4 0.99
Weight(kg) 1,029 < 1.5 115 0 - 1,370 36 0 -
1.5-
1.99
127 3 0.76 96 8 1.62
2-2.49 195 6 0.99 152 12 1.54
≥ 2.5 561 22 1.26 1,019 47 0.90
Axillary temperature °C 1,031 < 36 248 7 0.91 1,380 82 3 0.72
36-
37.4
546 8 0.47 752 24 0.63
37.5-
38.9
188 12 2.06 397 24 1.19
≥ 39 18 4 7.17 82 16 3.82
Mwaniki et al. BMC Infectious Diseases 2011, 11:301
http://www.biomedcentral.com/1471-2334/11/301
Page 7 of 10therapy. It is worth noting that the area under the ROC
curve in the validation period using the WHO suggested
signs did not significantly differ from chance (ROC area
0.5) for this age bracket. This suggests that the WHO
signs may largely not be able to discriminate between
those with or without meningitis in the first week of life.
In young infants’ age between 7 and 59 days old, there
were few cases of meningitis in the absence of a history
of fever. The presence of one or more of four clinical
features: a history of fever, a bulging fontanel, irritability,
convulsions, or an axillary temperature ≥ 39°C identified
85% of the cases of meningitis at admission. The lower
sensitivity of the signs suggested in the WHO guidelines
[3] may reflect the fact that in 8/48 (17%) meningitis
cases in the validation period, the only predictive clinical
sign was a history of fever. It has previously been
observed that rules requiring the presence of fever plus
another sign result in loss of sensitivity [10], our results
support this and suggest that neonates and young
infants requiring admission and with either history of
fever or measured axillary temperature ≥ 39°C should be
evaluated by LP for meningitis.
Table 4 Multivariate adjusted likelihood ratios for indicators of meningitis amongst neonates and young infants in the
derivation period with simplified scores.
Indicator Adjusted Likelihood Ratios Simplified scores
First Week of Life Age 7 to 59 days First week of life Age 7 to 59 days
History of Fever No 0.41 0.29 -1 -1
Yes 2.16 1.32 1 0
History of convulsions No 0.90 0.72 0 0
Yes 2.03 3.89 1 1
Bulging fontanel No 0.88 0.88 0 0
Yes 8.46 8.56 2 2
Irritability No 0.96 0.96 0 0
Yes 3.83 1.91 1 1
Axillary temperature °C < 36 0.94 0.78 0 0
36-37.4 0.62 0.70 0 0
37.5-38.9 1.59 1.14 0 0
≥ 39 3.57 2.76 1 1
constant +1
Composite total 66
Table 5 Overall performance of indicators of meningitis among neonates and young infants in the validation period
Indicators Number with
indicator
Number with
meningitis
Sensitivity
%
Specificity
%
PPV % NPV % N.N.
LP*
95%
CI
Bulging fontanel 24 11 17.5 (9.5 to
25.4)
99.1 (98.7
to 99.5)
45.8 (25.0
to 67.0)
96.5 (96.2
to 96.8)
2 1 to 5
Convulsions or any of the above 128 31 49.2(34.9 to
66.7)
93.3(92.7 to
94.1)
24.2 (17.2
to 32.8)
97.7 (97.0
to 98.5)
5 3 to 7
Axillary temp ≥ 39°C or any of the above 187 34 54.0(38.1 to
73.0)
89.4 (88.8
to 90.3)
18.2(12.8 to
24.6)
97.8(97.1 to
98.7)
75 t o
11
Agitation/irritability or any of the above 205 35 55.7(39.7 to
74.6)
88.3(87.6 to
89.1)
17.1(12.2 to
22.9)
97.9(97.1 to
98.7)
75 t o
11
History of fever or any of the above 738 49 77.8(58.7 to
93.7)
52.5 (51.2
to 53.1)
6.6 (5.0 to
8.0)
98.2 (96.6
to 99.5)
21 15 to
35
One or more of the WHO suggested
signs
636 44 69.8 (50.8
to 92.1)
59.1(58.3 to
60.1)
6.9 (5.0 to
9.1)
97.8 (96.5
to 99.4)
28 18 to
61
One or more of the WHO suggested
signs plus history of fever
1,113 55 87.3(65.0 to
100)
27 (26.0 to
27.5)
4.9 (3.7 to
5.7)
98 (94.5 to
100)
42 24 to
154
All admissions 1,512 63 100 0 - - - -
N.N.LP* Number of lumbar punctures needed to identify one case of Meningitis
Mwaniki et al. BMC Infectious Diseases 2011, 11:301
http://www.biomedcentral.com/1471-2334/11/301
Page 8 of 10We are encouraged that the clinical signs that we
identified are contained within the set of 14 signs pre-
dictive of sepsis identified from data collected in the
WHO multicenter study and were specifically associated
with meningitis [8-10]. The principal differences were
the inclusion of a history of fever and the exclusion of
drowsiness, lethargy, coma or reduced feeding, which
were not independently predictive.
Importantly, given the lack of microbiological labora-
tory resources at most hospitals in a rural African set-
ting, clinicians may consider LP not worthwhile.
However, we found that 90% of cases of meningitis in
this age group are identifiable macroscopically or by
basic CSF leukocyte counting. This underscores the
value of undertaking LP in the absence of full biochem-
ical or microbiological laboratory facilities.
Limitations
We did not perform LPs in infants with compromised
respiratory or circulatory status and many infants died
before LP was undertaken. It is therefore likely that we
missed meningitis in some of these cases, especially on
the first day of life and amongst those with very low
birth weight (although all sick newborns infants did
receive appropriate intravenous broad-spectrum antibio-
tics for presumed sepsis as standard policy). We
excluded these cases, but it may have reduced the pre-
dictive value of the signs we examined. Future studies
should explore acceptability of post mortem LPs in
resource poor nations, as this may aid in acquiring more
robust data. Ajayi and Mokoulu reported from Nigeria
that meningitis was rare in the first week of life. How-
ever in their study, three times fewer LPs were done in
infants in the first 72 hours of life [24]. Secondly, our
study lacked data on maternal and obstetric factors that
might predict meningitis. However, the yield from per-
forming LPs in infants in the first week of life with only
maternal risk factors has previously been found to be
low [25]. Thirdly, our findings are only from one site. It
is thus plausible that the findings from this part of sub-
Saharan Africa are not directly applicable to other areas
of the world.
Conclusions
In many hospitals in sub-Saharan Africa, neonates and
young infants are initially assessed and treated by staff
with little specific training or experience in neonatal or
young infant care. Although clinical signs predictive of
severe illness in this age bracket have been identified,
previous studies did not specifically address meningi-
tis [26]. Given that we found meningitis in only 1 in 21
investigated cases, building capacity and willingness to
undertake LPs and perform basic CSF microscopy is cri-
t i c a l .T h i sm a ya l s ob ec o s ts a v i n gb ya v o i d i n g
unnecessary extended antibiotic treatment and inpatient
stay in the majority of infants who do not have meningi-
tis Importantly, continuous inpatient review is vital
because one third of cases of meningitis are not recog-
nised at admission. Any neonate or young infant with
any one of the indicators indentified should be fully
investigated. Where LP is initially contra-indicated,
empirical treatment for meningitis should be started in
newborns and young infants, and LP conducted as early
as possible to determine the duration of antibiotic
therapy.
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